Aspirin, the wonder drug

Many studies have confirmed multiple functionality of aspirin in recent years. Here is the latest one - according to a study on 22,507 postmenopausal women, those who used aspirin had a 16% reduced risk of getting cancer, and a 13% reduced risk of cancer death, compared with women who never used it. Aspirin use was also associated with a 25% reduced risk of dying from coronary artery disease and an 18% reduction in all-cause mortality compared with those who never took aspirin.
The wonderful thing about aspirin is that other nonsteroidal anti-inflammatory drugs (which aspirin is classfied as), such as ibuprofen (Advil and other brands) and naproxen (Aleve and others) had no such multiple beneficial effect.

No comments: